Related Experiment Video
Updated: Aug 19, 2025

09:34
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
33.9K
Deep learning approaches for noncoding variant prioritization in neurodegenerative diseases.
Alexander Y Lan1,2,3, M Ryan Corces1,2,3
1Gladstone Institute of Neurological Disease, San Francisco, CA, United States.
Frontiers in Aging Neuroscience
|December 5, 2022
Summary
Deep learning models analyze complex genomic data to predict how noncoding genetic variants impact neurodegenerative diseases like Alzheimer's, aiding in understanding disease and developing treatments.
Area of Science:
- Genomics
- Computational Biology
- Neuroscience
Background:
- Noncoding genetic variants are crucial for understanding neurodegenerative dementias, but their complexity poses interpretation challenges.
- Next-generation sequencing generates vast genomic data, including transcription factor binding, gene expression, and chromatin interactions, offering potential disease insights.
- Interpreting large, complex genomic datasets is difficult for researchers, hindering progress in disease mechanism discovery.
Purpose of the Study:
- To review deep learning (DL) applications for predicting the impact of genetic variants on neurodegenerative disease pathogenesis.
- To organize and discuss DL model architectures, development philosophies, and interpretation methods relevant to genomic analysis.
- To highlight DL methods applicable to neurodegenerative diseases, with a focus on Alzheimer's disease.
Main Methods:
- Review of recent literature on deep learning in genomics and neurodegenerative disease research.
- Categorization of deep learning model architectures and their application in variant effect prediction.
- Discussion of interpretation strategies for deep learning models in the context of genomic data.
Main Results:
- Deep learning offers powerful tools for analyzing complex genomic data and identifying patterns related to disease.
- Various DL models and interpretation methods have emerged for predicting genetic variant impact.
- Broadly applicable DL methods can be fine-tuned for specific neurodegenerative disease contexts, particularly Alzheimer's.
Conclusions:
- Deep learning is a key technology for dissecting the role of noncoding variants in neurodegenerative diseases.
- Integrating DL with genomic data analysis promises advancements in disease prognostication and therapeutic development.
- The intersection of neurodegeneration, genomics, and deep learning represents a rapidly evolving and promising research frontier.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Treatment
240
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
240
Alzheimer's Disease: Overview
612
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
612

